Meanwhile, AEA inhibits the viability of A549, SW620, and DLD1 cells, which are related to NSCLC and colon cancer, through the activation of CB1 and CB2 (Ravi et al., 2014; Kuc et al., 2012; Proto et al., 2012; Pasquariello et al., 2009). The gene discussed is CNR2; the disease is non-small cell lung carcinoma.